Evotec Neurosciences GmbH
Records under this name other than the patents Evotec Neurosciences GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 6 of 6 · Back to Evotec Neurosciences GmbH
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,574,861 | PPM1E proteins and nucleic acids as targets for neurodegenerative diseases Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,501,473 | Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome Formerly held Lapsed on the fee record Ended Aug 6, 2017 · USPTO record | Lapsed on the fee record | Ended Aug 6, 2017 | USPTO record |
| US 7,554,003 | Invertebrate animal model with neurodegenerative phenotype for screening and testing substances Lapsed on the fee record Ended Jun 30, 2017 · USPTO record | Lapsed on the fee record | Ended Jun 30, 2017 | USPTO record |
| US 7,968,535 | Use of azapaullones for preventing and treating pancreatic autoimmune disorders Formerly held Lapsed on the fee record Ended Jun 28, 2015 · USPTO record | Lapsed on the fee record | Ended Jun 28, 2015 | USPTO record |
| US 7,211,563 | Protein disulfide isomerase and ABC transporter homologous proteins involved in the regulation of energy homeostasis Formerly held Lapsed on the fee record Ended May 1, 2015 · USPTO record | Lapsed on the fee record | Ended May 1, 2015 | USPTO record |
| US 7,185,709 | Expandable tubing and method Formerly held Surrendered on reissue Surrendered on reissue Sep 2, 2014 · USPTO record | Surrendered on reissue | Surrendered on reissue Sep 2, 2014 | USPTO record |